To Be Discontinued Tablet Psychiatry
Guanfacine Hydrochloride Tab · 4 active FDA presentation rows for this drug
Brand: GUANFACINE
FDA lists Guanfacine Hydrochloride Tab as To Be Discontinued (Actavis Pharma, Inc.).
No availability text on this FDA row.
Guanfacine Hydrochloride Tablet, Extended Release: To Be Discontinued
FDA availability text is not recorded on this row. 4 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Guanfacine Hydrochloride Tablet, Extended Release
- Manufacturer
- Actavis Pharma, Inc.
- Dosage Form
- Tablet
- Presentation
- Guanfacine Hydrochloride, Tablet, Extended Release, 3 mg (NDC 0228-2853-11)
- Package NDC
- 0228-2853-11
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- Nov 13, 2025
- Last Updated
- Nov 13, 2025
- Therapeutic Category
- Psychiatry
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
A business decision was made to discontinue manufacture of the drug.
Full Drug Profile
guanfacine
Side effects, interactions, warnings & more
Nearby, Other Guanfacine Shortage Records
FDA reason on file: A business decision was made to discontinue manufacture of the drug. General shortage guidance lives on the tracker hub.